mhurhangee/ep-ind-claims huggingface dataset:
A fastening fitting for fastening a panel to a drawer, the fastening fitting comprising panel fitting parts (1, 1') for mounting on side walls of the drawer and panel mounting parts (2, 2', 2") for mounting on a rear side of the panel, the panel fitting parts (1, 1') receiving the panel mounting parts (2, 2', 2"), these being connectable by means of locking means (7, 7', 7") of the panel fitting parts (1, 1') and locking pins (3, 3', 3") of the panel mounting parts (2, 2', 2"), each of the panel mounting parts (2, 2', 2") comprising means (4, 4', 4") for adjusting the inclination of the panel, which means are operatively connected in each case to an adjusting body (5, 5'), designed as an eccentric pin, of the panel fitting parts (1, 1') and pivot the panel about an axis running parallel to the bottom or top side of the drawer, and wherein the locking means (7', 7") are each displaceably arranged in a guide section and are movable along the guide section between an open position of the locking means (7', 7") and a closed position of the locking means (7', 7"), characterised in that in that either the means for adjusting the inclination comprise a fork of the panel mounting part, which fork is directed towards the panel fitting part and receives the eccentric bolt, or in that the means for adjusting the inclination comprise an elongated guide plate arranged vertically on the panel fitting part, the eccentric bolt or one end of the guide plate being alternately one end of the guide plate can be placed alternately against end contact surfaces (4', 4") of the cover mounting part and an additional cover mounting part (2") arranged above the latter, and a second end of the guide plate being connected to the eccentric bolt. in that either the means for adjusting the inclination comprise a fork of the panel mounting part, which fork is directed towards the panel fitting part and receives the eccentric bolt, or in that the means for adjusting the inclination comprise an elongated guide plate arranged vertically on the panel fitting part, the eccentric bolt or one end of the guide plate being alternately one end of the guide plate can be placed alternately against end contact surfaces (4', 4") of the cover mounting part and an additional cover mounting part (2") arranged above the latter, and a second end of the guide plate being connected to the eccentric bolt.
A method in a network node for use in a dual connectivity mode to communicate with wireless devices, WDs, according to Long Term Evolution, LTE, and to communicate with WDs according to New Radio, NR, the method comprising: scheduling uplink and downlink signals to be transmitted and received by a first set of WDs such that the first set of WDs are operable to: - receive downlink signals and transmit uplink signals using LTE only in even Transmission Time Intervals, TTIs, of LTE; and - transmit uplink signals using NR only in UL TTIs of NR that do not collide with even TTIs of LTE. - receive downlink signals and transmit uplink signals using LTE only in even Transmission Time Intervals, TTIs, of LTE; and - transmit uplink signals using NR only in UL TTIs of NR that do not collide with even TTIs of LTE.
A T lymphocyte comprising an artificial cell death polypeptide comprising an apoptosis-inducing domain, wherein said polypeptide is dimerizable using an antibody, and wherein when said antibody dimerizes said polypeptide, an apoptosis-inducing signal is generated in said T lymphocyte, wherein said artificial cell death polypeptide is a transmembrane protein comprising an extracellular domain that comprises an epitope or mimotope, a transmembrane domain, and an intracellular domain comprising said apoptosis-inducing domain, wherein said apoptosis-inducing domain is or comprises caspase 3, caspase 8 or caspase 9, and wherein said antibody is rituximab and said epitope or mimotope is a CD20 epitope or mimotope that binds to said rituximab; said antibody is tositumumab and said epitope or mimotope is a CD20 epitope or mimotope that binds to said tositumumab; said antibody is ibritumomab and said epitope or mimotope is a CD20 epitope or mimotope that binds said ibritumomab; said antibody is ofatumumab and said epitope or mimotope is a CD20 epitope or mimotope that binds said ofatumumab; said antibody is alemtuzumab and said epitope or mimotope is a CD52 epitope or mimotope that binds to said alemtuzumab; said antibody is basiliximab and said epitope or mimotope is a CD25 epitope or mimotope that binds said basiliximab; said antibody is daclizumab and said epitope or mimotope is a CD25 epitope or mimotope that binds said daclizumab; said antibody is brentuximab and said epitope or mimotope is a CD30 epitope or mimotope that binds said brentuximab; said antibody is belimumab and said epitope or mimotope is a B-cell activating factor (BAFF) epitope or mimotope that binds said belimumab; said antibody is cetuximab and said epitope or mimotope is an epidermal growth factor receptor (EGFR) epitope or mimotope that binds said cetuximab; said antibody is panitumumab and said epitope or mimotope is an epidermal growth factor receptor (EGFR) epitope or mimotope that binds said panitumumab; said antibody is efalizumab and said epitope or mimotope is a CD11a epitope or mimotope that binds to said efalizumab; said antibody is ipilimumab and said epitope or mimotope is a CD152 epitope or mimotope that binds said ipilimumab; or said antibody is natalizumab and said epitope or mimotope is an alpha-4 integrin epitope or mimotope that binds said natalizumab.
A method for preparing an anode slurry, comprising the steps of: 1) mixing a dispersant with a first solvent to form a dispersant solution; 2) dispersing a silicon-based material and a first conductive agent in the dispersant solution to form a first suspension; 3) homogenizing the first suspension by a homogenizer to obtain a homogenized first suspension; 4) mixing a binder material with a second solvent to form a binder solution; 5) dispersing a second conductive agent in the binder solution to form a second suspension; 6) mixing the homogenized first suspension with the second suspension to form a third suspension; and 7) mixing a carbon active material with the third suspension to form the anode slurry; wherein first conductive agent is selected from the group consisting of carbon, carbon black, acetylene black, Super P, graphene, graphene nanoplatelets, carbon fibres, carbon nano-fibers, graphitized carbon flake, carbon tubes, carbon nanotubes, activated carbon, mesoporous carbon, and combinations thereof; wherein the particle size of the first conductive agent is from about 20 nm to about 100 nm; wherein the particle size of the second conductive agent is from about 1 μm to about 10 μm; wherein the particle size of the silicon-based material is from about 10 nm to about 800 nm; and wherein the particle size of the first conductive agent is smaller than the particle size of the second conductive agent, the particle sizes of the first and second conductive agents and the silicon-based material all being determined via laser diffraction analysis. 1) mixing a dispersant with a first solvent to form a dispersant solution; 2) dispersing a silicon-based material and a first conductive agent in the dispersant solution to form a first suspension; 3) homogenizing the first suspension by a homogenizer to obtain a homogenized first suspension; 4) mixing a binder material with a second solvent to form a binder solution; 5) dispersing a second conductive agent in the binder solution to form a second suspension; 6) mixing the homogenized first suspension with the second suspension to form a third suspension; and 7) mixing a carbon active material with the third suspension to form the anode slurry; wherein first conductive agent is selected from the group consisting of carbon, carbon black, acetylene black, Super P, graphene, graphene nanoplatelets, carbon fibres, carbon nano-fibers, graphitized carbon flake, carbon tubes, carbon nanotubes, activated carbon, mesoporous carbon, and combinations thereof; wherein the particle size of the first conductive agent is from about 20 nm to about 100 nm; wherein the particle size of the second conductive agent is from about 1 μm to about 10 μm; wherein the particle size of the silicon-based material is from about 10 nm to about 800 nm; and wherein the particle size of the first conductive agent is smaller than the particle size of the second conductive agent, the particle sizes of the first and second conductive agents and the silicon-based material all being determined via laser diffraction analysis.
A composition suitable for use as an additive system in a formulated lubricant, said composition comprising at least one sulfur-containing extreme pressure agent, at least one phosphorus-containing antiwear agent, and at least one triazole-containing species, wherein the at least one sulfur-containing extreme pressure agent is selected from the group consisting of sulfurized oligomers of C2-C8 monoolefins, olefin sulfides, and dialkyl or diaryl polysulfides; wherein the at least one phosphorus-containing antiwear agent is selected from the group consisting of mono, di and trihydrocarbyl phosphites; mono, di and trihydrocarbyl phosphates; mono, di and trihydrocarbyl mono, di, tri, tetrathiophosphates; mono, di and trihydrocarbyl mono, di, tri, tetrathiophosphites, hydrocarbyl phosphonates and thiophosphonates; hydrocarbyl phosphonites and thiophosphonites; and amine salts thereof; said composition further characterized by having a mass ratio of sulfur to phosphorus of 1:1 to less than 10:1, a mass ratio of phosphorus to nitrogen of greater than 2:1 and no greater than 5:1, and a mass ratio of sulfur to triazole-containing species of 10:1 and no more than 150:1.
Surgical instrument for nasal osteotomy, set up of at least a couple of lever arms (1, 2, 6, 7) and a couple of sharp spouts (9, 10) mutually hinged at least in a rotation fulcrum (3, 8), characterised in that said sharp spouts (9, 10) show an active portion with a cross section having an acute angle, in which the acute angles of the two sharp spouts (9, 10) are opposed and said active portion extends for a length greater than 30 mm and shorter than 45 mm.
A piezoelectric film using a mixture of at least two copolymers of vinylidene fluoride, VDF, and trifluoroethylene, TrFE, a copolymer being denoted PVT, a first copolymer being denoted as PVT1 and a second copolymer being denoted as PVT2, characterised in that PVT1 is a PVT having a VDF polymerization ratio of 85 mol% and TrFE polymerization ratio of 15 mol% (PVT85/15), PVT2 is a PVT having a VDF polymerization ratio of 81 mol% and TrFE polymerization ratio of 19 mol% (PVT81/19), and wherein a mixing ratio of PVT1 (PVT85/15) is in a the range of 30 wt% to 70 wt% relative to the total weight of the mixture.
A method for providing increased carotenoid content to a plant comprising overexpressing by transformation with an exogenous nucleic acid a naturally occurring allelic variant of phytoene synthase 1 in a plant, wherein the allelic variant is such that amino acid residue 168 is an N and amino acid residue 257 is a P, designated as the NP variant of PSY1.
An optically stable aqueous surfactant composition comprising: a) from 0.05 to 6 wt%, on active polymer basis, of a low molecular weight, non-crosslinked, linear emulsion polymer having a number average molecular wt. ranging from 10,000 to 100,000 Daltons, measured as indicated in the Methods Description section of the specification, said polymer comprising from 51 to 75 wt.% of polymerized residues of at least one ethylenically unsaturated C 3 -C 6 carboxylic acid monomer, from 25 to 49 wt.% of polymerized residues of a at least one C 1 -C 4 alkyl (meth)acrylate monomer, and from 0 to 1 wt.% of a residue of a chain transfer agent, based on 100 wt. parts of monomer; and b) at least one surfactant. a) from 0.05 to 6 wt%, on active polymer basis, of a low molecular weight, non-crosslinked, linear emulsion polymer having a number average molecular wt. ranging from 10,000 to 100,000 Daltons, measured as indicated in the Methods Description section of the specification, said polymer comprising from 51 to 75 wt.% of polymerized residues of at least one ethylenically unsaturated C 3 -C 6 carboxylic acid monomer, from 25 to 49 wt.% of polymerized residues of a at least one C 1 -C 4 alkyl (meth)acrylate monomer, and from 0 to 1 wt.% of a residue of a chain transfer agent, based on 100 wt. parts of monomer; and b) at least one surfactant.
An access point type communication device configured to allocate a plurality of random access resources to a set of client type communication devices (120a-c), wherein the access point type communication device comprises: a controller configured to maintain a set of association identifiers, wherein each identifier of the set of association identifiers is configured to identify a respective client type communication device of the set of client type communication devices (120a-c), and a set of random access identifiers, wherein the controller is configured to assign each random access identifier of the set of random access identifiers to a respective association identifier of the set of association identifiers; wherein the set of random access identifiers is a sequence of integers; an allocator configured to allocate the plurality of random access resources to the set of client type communication devices (120a-c) on the basis of the set of random access identifiers; a transceiver configured to transmit to each client type communication device of the set of client type communication devices (120a-c) the respective random access identifier of the set of random access identifiers and information about the allocation of the plurality of random access resources to the set of client type communication devices based on the set of random access identifiers by transmitting a first element and a size of the sequence of integers or a number of the random access identifiers assigned to a current random access frame. a controller configured to maintain a set of association identifiers, wherein each identifier of the set of association identifiers is configured to identify a respective client type communication device of the set of client type communication devices (120a-c), and a set of random access identifiers, wherein the controller is configured to assign each random access identifier of the set of random access identifiers to a respective association identifier of the set of association identifiers; wherein the set of random access identifiers is a sequence of integers; an allocator configured to allocate the plurality of random access resources to the set of client type communication devices (120a-c) on the basis of the set of random access identifiers; a transceiver configured to transmit to each client type communication device of the set of client type communication devices (120a-c) the respective random access identifier of the set of random access identifiers and information about the allocation of the plurality of random access resources to the set of client type communication devices based on the set of random access identifiers by transmitting a first element and a size of the sequence of integers or a number of the random access identifiers assigned to a current random access frame.
A wearable device worn on a body of a user, the wearable device comprising: a sensor comprising a gyroscopic sensor and an acceleration sensor configured to detect data related to a movement of the user; and a biometric sensor configured to sense information related to a biometric signal of the user; a position sensor configured to a detect a location of the user; a touch input unit; a display; a communicator; and at least one processor configured to: determine, based on the information related to the biometric signal of the user, whether the user is in a poor health state; when a touch input is received, select, based on the determination, at least one string from a plurality of strings based on state information of the user wherein the state information of the user is information about a biometric signal of the user; control the display to display the selected at least one string for allowing the user to edit the selected at least one string; control the communicator to transmit a message including the selected string to a receiver device with the location of the user. a sensor comprising a gyroscopic sensor and an acceleration sensor configured to detect data related to a movement of the user; and a biometric sensor configured to sense information related to a biometric signal of the user; a position sensor configured to a detect a location of the user; a touch input unit; a display; a communicator; and at least one processor configured to: determine, based on the information related to the biometric signal of the user, whether the user is in a poor health state; when a touch input is received, select, based on the determination, at least one string from a plurality of strings based on state information of the user wherein the state information of the user is information about a biometric signal of the user; control the display to display the selected at least one string for allowing the user to edit the selected at least one string; control the communicator to transmit a message including the selected string to a receiver device with the location of the user. determine, based on the information related to the biometric signal of the user, whether the user is in a poor health state; when a touch input is received, select, based on the determination, at least one string from a plurality of strings based on state information of the user wherein the state information of the user is information about a biometric signal of the user; control the display to display the selected at least one string for allowing the user to edit the selected at least one string; control the communicator to transmit a message including the selected string to a receiver device with the location of the user.
Method of operating a drive apparatus in a window screening kit such as a blind, venetian blind, awning or roller shutter for a window, said method comprising the steps of: powering an electrical motor in said drive apparatus from a power supply unit for driving a moveable part of the window screening kit between positions wherein said power supply unit includes a battery storage for energy storing and powering said electrical motor, at least one solar power cell for powering said electrical motor and/or said battery storage, and a regulator unit, characterized by detecting the state of charge such as voltage values of said battery storage and detecting temperature values in or at said battery storage with at least voltage and temperature detectors, comparing said detected state of charge and temperature values in said regulator unit with predefined threshold values (Tthr, Vthr) of the state of charge and the temperature for said battery storage, and regulating powering of said battery storage with said regulator unit in response to the comparison of detected values. powering an electrical motor in said drive apparatus from a power supply unit for driving a moveable part of the window screening kit between positions wherein said power supply unit includes a battery storage for energy storing and powering said electrical motor, at least one solar power cell for powering said electrical motor and/or said battery storage, and a regulator unit, characterized by detecting the state of charge such as voltage values of said battery storage and detecting temperature values in or at said battery storage with at least voltage and temperature detectors, comparing said detected state of charge and temperature values in said regulator unit with predefined threshold values (Tthr, Vthr) of the state of charge and the temperature for said battery storage, and regulating powering of said battery storage with said regulator unit in response to the comparison of detected values.
A composition comprising: a nanostructure; and a C5-C8 carboxylic acid ligand bound to a surface of the nanostructure wherein the nanostructure is an InP/ZnS x Se 1-x /ZnS core/shell quantum dot, where 0<x<1.
A system for controlling diesel emissions with two or more reagent injectors, comprising: a first injector for injecting a first reagent into an exhaust stream from a diesel engine, wherein said first injector is positioned upstream of at least one of a diesel particulate filter and a lean NOx trap; a second injector for injecting a second reagent into the exhaust stream, wherein said second injector is positioned downstream of said first injector and upstream of a selective catalytic reduction catalyst, and wherein the second reagent is different from the first reagent; a first pump for providing the first reagent to said first injector; a second pump for providing the second reagent to said second injector; a control unit for controlling the injection of both the first reagent and the second reagent; the system being characterised by further comprising: a first tank connected to the first pump and comprising the first reagent; and a second tank connected to the second pump and comprising the second reagent, and wherein said control unit is adapted to receive an alert signal indicative of the second tank reaching a predetermined low level; and wherein said control unit transmits at least one control signal to stop the injecting of the second reagent and to begin injecting the first reagent upon receiving the alert signal. a first injector for injecting a first reagent into an exhaust stream from a diesel engine, wherein said first injector is positioned upstream of at least one of a diesel particulate filter and a lean NOx trap; a second injector for injecting a second reagent into the exhaust stream, wherein said second injector is positioned downstream of said first injector and upstream of a selective catalytic reduction catalyst, and wherein the second reagent is different from the first reagent; a first pump for providing the first reagent to said first injector; a second pump for providing the second reagent to said second injector; a control unit for controlling the injection of both the first reagent and the second reagent; a first tank connected to the first pump and comprising the first reagent; and a second tank connected to the second pump and comprising the second reagent, and wherein said control unit is adapted to receive an alert signal indicative of the second tank reaching a predetermined low level; and wherein said control unit transmits at least one control signal to stop the injecting of the second reagent and to begin injecting the first reagent upon receiving the alert signal.